Trabectedin has not been approved for marketing in Chinese Mainland, and patients need to obtain the drug through overseas channels.

1. Current listing status

(1) Approval status: As of September 2025, the National Medical Products Administration has not yet released the marketing authorization for quetiapine

(2) Clinical progress: Domestic clinical trial information shows that the drug is still in the evaluation stage

(3) Comparison reference: Drugs of the same type, such as Rubicitidine and Tukatinib, are also not on the market

2 alternative ways of obtaining

(1) Overseas drug purchase: It can be legally purchased through regions such as Hong Kong, Macau, or countries where the original drug is listed

(2) Clinical trials: Pay attention to drug clinical trial projects conducted in domestic tertiary hospitals

(3) Special channel: Some medical institutions may apply for compassionate medication procedures

3 Medication Safety Tips

(1) Channel verification: Obtain drugs through legitimate medical institutions to avoid the risk of counterfeit drugs

(2) Cold chain transportation: This medicine needs to be strictly stored at 2-8 ℃

(3) Professional guidance: Before use, the treatment plan needs to be evaluated by a specialist oncologist